While these anti-HIV prospects have been a long time coming, their potential to slow the global AIDS epidemic could be truly awesome: A mathematical model produced by the London School of Hygiene and Tropical Medicine estimated that if just 20 percent of women in the world's 73 poorest countries used microbicides half the time, and if those microbicides were only 60 percent effective, it would prevent more than 2.5 million new HIV infections every three years.And the dilemma:
The catch: None of these drugs has yet been approved by the Food and Drug Administration, and most are years away from retail shelves. Big Pharma, which has the resources to usher them smoothly to market, has pretty much opted out. To be blunt: It is infinitely more lucrative to treat HIV than stop it.
Spring 2006: Guest Bloggers!
Rishi | Scott | Emily
Echan | Robert | ToastyKen